Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial in 'At Risk' Humans Investigating the Cognitive Benefits of a Combined Flavonoid/Fatty Acid Intervention and Underlying Mechanisms of Action: The COGNITIVE AGING NUTRITION and NEUROGENESIS (CANN) Trial

NCT02525198 is registered in ClinicalTrials.gov with University of East Anglia as lead sponsor.

NCT NCT02525198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02525198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial in 'At Risk' Humans Investigating the Cognitive Benefits of a Combined Flavonoid/Fatty Acid Intervention and Underlying Mechanisms of Action: The COGNITIVE AGING NUTRITION and NEUROGENESIS (CANN) Trial
Lead sponsor
University of East Anglia
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2015
Completion date
March 31, 2018
Enrollment
259 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment, subjective memory impairment